Christof Schneider

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 20, 2022
Circulating Tumor DNA-Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax.

Moritz Fürstenau, Jonathan Weiss, Adam Giza

Pageof 1